These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37220281)

  • 1. The psychosocial impacts of vitiligo, psoriasis, and alopecia areata on pediatric patients.
    Cruz S; Lei DK; Carr H; Rosenblatt A
    Dermatol Online J; 2023 Apr; 29(2):. PubMed ID: 37220281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual group visits to reduce psychosocial distress and racial disparities in pediatric vitiligo and alopecia areata patients.
    Khosla NN; Grullon K; Rosenblatt AE
    Pediatr Dermatol; 2021 Nov; 38 Suppl 2():132-134. PubMed ID: 34448243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between skin diseases and quality of life: a comparison of psoriasis, vitiligo, and alopecia areata.
    Ghajarzadeh M; Ghiasi M; Kheirkhah S
    Acta Med Iran; 2012; 50(7):511-5. PubMed ID: 22930385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alexithymia in different dermatologic patients.
    Dehghani F; Dehghani F; Kafaie P; Taghizadeh MR
    Asian J Psychiatr; 2017 Feb; 25():42-45. PubMed ID: 28262172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and depression in pediatric patients with vitiligo and alopecia areata and their parents: A cross-sectional controlled study.
    Savaş Erdoğan S; Falay Gür T; Doğan B
    J Cosmet Dermatol; 2021 Jul; 20(7):2232-2239. PubMed ID: 33089618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.
    Toussi A; Barton VR; Le ST; Agbai ON; Kiuru M
    J Am Acad Dermatol; 2021 Jul; 85(1):162-175. PubMed ID: 32561373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of pediatric cutaneous autoimmunity: The sister diseases vitiligo and alopecia areata.
    Silverberg N
    Clin Dermatol; 2022; 40(4):363-373. PubMed ID: 35183681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic interventions to lessen the psychosocial effect of vitiligo in children: A review.
    Cadmus SD; Lundgren AD; Ahmed AM
    Pediatr Dermatol; 2018 Jul; 35(4):441-447. PubMed ID: 29766546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of disease and quality of life in parents of children with alopecia areata, totalis, and universalis: A prospective, cross-sectional study.
    Putterman E; Patel DP; Andrade G; Harfmann KL; Hogeling M; Cheng CE; Goh C; Rogers RS; Castelo-Soccio L
    J Am Acad Dermatol; 2019 May; 80(5):1389-1394. PubMed ID: 30633941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease.
    Čeović R; Desnica L; Pulanić D; Serventi Seiwerth R; Ilić I; Grce M; Mravak Stipetić M; Klepac Pulanić T; Bilić E; Bilić E; Milošević M; Vrhovac R; Nemet D; Pavletic SZ
    Croat Med J; 2016 Jun; 57(3):229-38. PubMed ID: 27374824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor and vitamin D: Two concordant players controlling depression among alopecia areata and vitiligo patients: A case-control study.
    Dawoud NM; Rajab AZ; El-Hefnawy SM; El-Bayoumy AM; Salem AM; Seleit I
    J Cosmet Dermatol; 2023 Aug; 22(8):2343-2351. PubMed ID: 36999446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric symptomatology and health-related quality of life in children and adolescents with alopecia areata.
    Bilgiç Ö; Bilgiç A; Bahalı K; Bahali AG; Gürkan A; Yılmaz S
    J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1463-8. PubMed ID: 24237476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting.
    Zagona-Prizio C; Yousif J; Grant C; Mehta M; Rosmarin D; Silverberg N; Tan J; Larocca C; Shinohara M; Mostaghimi A; Kim B; Gulliver S; Gulliver W; Siegel D; Perez-Chada L; Merola J; Gottlieb A; Armstrong A
    J Drugs Dermatol; 2022 Aug; 21(8):867-874. PubMed ID: 35946973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stigma of skin disease.
    Wu JH; Cohen BA
    Curr Opin Pediatr; 2019 Aug; 31(4):509-514. PubMed ID: 31188167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of psoriasis, and alopecia areata with trachyonychia in a pediatric patient with Turner Syndrome.
    Dogruk Kacar S; Ozuguz P; Polat S
    Arch Argent Pediatr; 2014 Oct; 112(5):e209-12. PubMed ID: 25192537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychosocial impact of acne, vitiligo, and psoriasis: a review.
    Nguyen CM; Beroukhim K; Danesh MJ; Babikian A; Koo J; Leon A
    Clin Cosmet Investig Dermatol; 2016; 9():383-392. PubMed ID: 27799808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alemtuzumab-induced Alopecia areata - a case report and systematic literature review of adverse events associated with Alemtuzumab.
    Dikeoulia E; Neufeld M; Pawlitzki M; Böhm M
    J Dtsch Dermatol Ges; 2021 Aug; 19(8):1159-1163. PubMed ID: 33973347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders.
    Manzoni AP; Weber MB; Nagatomi AR; Pereira RL; Townsend RZ; Cestari TF
    An Bras Dermatol; 2013; 88(6):894-9. PubMed ID: 24474096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comorbidities in vitiligo: comprehensive review.
    Dahir AM; Thomsen SF
    Int J Dermatol; 2018 Oct; 57(10):1157-1164. PubMed ID: 29808541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.